The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc shares valued at $456,400 were sold by Mercier Johanna on Nov 06 ’24. At $91.28 per share, Mercier Johanna sold 5,000 shares. The insider’s holdings dropped to 73,127 shares worth approximately $6.56 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Parsey Merdad sold 25,590 shares, netting a total of over 2,341,485 in proceeds. Following the sale of shares at $91.50 each, the insider now holds 99,599 shares.
Before that, MERDAD V PARSEY had added 25,590 shares to its account. In a trade valued at $2,341,485, the Officer bought Gilead Sciences, Inc shares for $91.50 each.
As published in their initiating research note from Wolfe Research on November 15, 2024, Gilead Sciences, Inc [GILD] has been an Outperform and the price target has been revised to $110. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. As of November 08, 2024, Maxim Group has decreased its “Buy” rating to a “Hold” for GILD. Earlier on October 21, 2024, Leerink Partners upgraded its rating. Their new recommendation was “an Outperform” for GILD stock which previously was a “a Market perform”.
Analyzing GILD Stock Performance
During the last five days, there has been a drop of approximately -2.55%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 10.80%. Shares of the company reached a 52-week high of $98.90 on 11/11/24 and a 52-week low of $62.07 on 05/31/24. A 50-day SMA is recorded $87.28, while a 200-day SMA reached $75.09. Nevertheless, trading volume fell to 4.06 million shares from 4.78 million shares the previous day.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 88.57, which, if violated, would cause prices to drop to 87.39. In the upper region, resistance lies at 90.44. The next price resistance is at 91.13. RSI (Relative Strength Index) is 50.77 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.10, which suggests the price will decrease in the coming days. Percent R is at 71.29%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
